Personal profile
Fingerprint
Dive into the research topics where Polrat Wilairatana is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Demethoxycurcumin exhibits amoebicidal activity against Acanthamoeba triangularis trophozoites and cysts and inhibits encystation
Boonhok, R., Senghoi, W., Tedasen, A., Sangkanu, S., Lim, C. L., Pereira, M. D. L., Rahmatullah, M., Wilairatana, P., Wiart, C., Dolma, K. G., Paul, A. K., Gupta, M., Rahman, M. A., Bunluepuech, K., Sundara, S., Mahboob, T. & Nissapatorn, V., Jan 2026, In: Current Research in Parasitology and Vector-Borne Diseases. 9, 100362.Research output: Contribution to journal › Article › peer-review
Open Access -
Prognostic value of sputum HMGB1 in smear-negative and smear-positive pulmonary TB
Kamolratanakul, S., Bhunyakarnjanarat, T., Ariyanon, W., Wilairatana, P., Leelahavanichkul, A. & Chancharoenthana, W., 27 Feb 2026, In: International Journal of Tuberculosis and Lung Disease. 30, 3, p. 100-106 7 p.Research output: Contribution to journal › Article › peer-review
-
RETRACTED: Neuroinflammatory Markers: Key Indicators in the Pathology of Neurodegenerative Diseases (Molecules, (2022), 27, 10, (3194), 10.3390/molecules27103194)
Rauf, A., Badoni, H., Abu-Izneid, T., Olatunde, A., Rahman, M. M., Painuli, S., Semwal, P., Wilairatana, P. & Mubarak, M. S., Mar 2026, In: Molecules. 31, 6, 951.Research output: Contribution to journal › Comment/debate
Open Access -
Retraction notice to "Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?" (Biomedicine & Pharmacotherapy, (2022), 154, C, (113522), (S0753332222009118), 10.1016/j.biopha.2022.113522)
Dhawan, M., Saied, A. R. A., Mitra, S., Alhumaydhi, F. A., Bin Emran, T. & Wilairatana, P., Apr 2026, In: Biomedicine and Pharmacotherapy. 197, 119215.Research output: Contribution to journal › Comment/debate
Open Access -
Retraction notice to "Recent advancements of nanoparticles application in cancer and neurodegenerative disorders: At a glance"(Biomedicine & Pharmacotherapy, (2022), 153, C, (113305), (S0753332222006941), 10.1016/j.biopha.2022.113305)
Rahman, M. M., Islam, M. R., Akash, S., Harun-Or-Rashid, M., Ray, T. K., Rahaman, M. S., Islam, M., Anika, F., Hosain, M. K., Aovi, F. I., Hemeg, H. A., Rauf, A. & Wilairatana, P., 2026, (Accepted/In press) In: Biomedicine and Pharmacotherapy. 119424.Research output: Contribution to journal › Comment/debate
Open Access
Prizes
-
File
-
-
2024 World's Top 2% Scientists by Stanford University: Career-Long
Wilairatana, P. (Recipient), 2024
Prize
-